# A Study of CNSA-001 in Women With Diabetic Gastroparesis

> **NCT03712124** · PHASE2 · COMPLETED · sponsor: **PTC Therapeutics** · enrollment: 21 (actual)

## Conditions studied

- Gastroparesis

## Interventions

- **DRUG:** CNSA-001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03712124
- **Lead sponsor:** PTC Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-27
- **Primary completion:** 2019-09-08
- **Final completion:** 2019-10-08
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2022-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03712124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03712124, "A Study of CNSA-001 in Women With Diabetic Gastroparesis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03712124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*